Epidemiological manifestations of tuberculosis infection in the Omsk region: dynamics and trends

Background. Tuberculosis (TB) infection remains relevant as one of the leading public health problems in Russia.

The aim. To characterize the dynamics and trends of epidemiological manifestations of TB infection in the Omsk region.

Materials and methods. An observational descriptive-evaluative epidemiological study was carried out in the Omsk region from 2009 to 2021. The data available in the Federal statistical observation forms NN 7, 8, and 33, and results of the bacteriological study of patients with respiratory TB were analyzed.

Results. In the Omsk region, an improvement in the epidemiological situation was observed from 2009 to 2021. It was associated with a decrease in TB prevalence by 3.7 times (from 325.6 to 86.7), mortality – by 5.8 times (from 21.1 to 3.6), incidence – by 2.7 times (from 130.7 to 48.4 per 100,000). At the same time, proportion of microscopy/culture-positive patients infected with multidrug-resistant Mycobacterium tuberculosis strains increased from 9.2 to 29.8 % among all patients, and from 15.5 to 30.6 % among newly diagnosed patients. There was a trend towards an increase in the number of cases with primary extensive drug resistance of M. tuberculosis. The incidence of tuberculosis associated with HIV infection has increased 10 times and reached 15.6 per 100,000 population.

Conclusions. In the Omsk region, there is a change in the structure of M. tuberculosis strains with a predominance of multiple and extensive drug resistance along with decrease in TB incidence and mortality. New approaches are needed to organize the system of epidemiological surveillance and control of TB infection.

1. WHO. Tuberculosis: Fact sheet. 2021. URL: https://www.who.int/health-topics/tuberculosis#tab=tab_1 [date of access: 02.10.2022].

2. Floyd K, Glaziou P, Houben RMGJ, Sumner T, White RG, Raviglione M. Global tuberculosis targets and milestones set for 2016–2035: Definition and rationale. Int J Tuberc Lung Dis. 2018; 22(7): 723-730. doi: 10.5588/ijtld.17.0835

3. WHO. Global tuberculosis report. 2021. URL: https://www.who.int/teams/global-tuberculosis-programme/data [date of access: 14.10.2022].

4. WHO. Tuberculosis surveillance and monitoring in Europe 2022–2020 data. Copenhagen: WHO Regional Office for Europe and Stockholm: European Centre for Disease Prevention and Control; 2022. URL: https://www.ecdc.europa.eu/sites/default/files/documents/Tuberculosis-surveillance-monitoring-europe-2022_0.pdf [date of access: 30.09.2022].

5. Shilova MV. Tuberculosis in population of Russian Federation. Medical alphabet. 2019; 1(15): 7-18. (In Russ.). doi: 10.33667/2078-5631-2019-1-15(390)-7-18

6. Zhdanova S, Heysell SK, Ogarkov O, Boyarinova G, Alexeeva G, Pholwat S, et al. Primary multidrug-resistant Mycobacterium tuberculosis in 2 regions, Eastern Siberia, Russian Federation. Emerg Infect Dis. 2013; 19(10): 1649-1652. doi: 10.3201/eid1910.121108

7. Vyazovaya АА, Pasechnik OA, Gerasimova АА, Mokrousov IV. The population structure of Beijing family of Mycobacterium tuberculosis in Western Siberia. Tuberculosis and Lung Diseases. 2020; 98(5): 32-36. (In Russ.). doi: 10.21292/2075-1230-2020-985-32-36

8. Pasechnik OA, Vyazovaya AA, Bloch AI, Yarusova IV, Tatarintseva MP, Mokrousov IV. Assessment of the prevalence and epidemic spread of strains of ancient, and modern sublineages of the Mycobacterium tuberculosis Beijing genotype in Omsk region. Epidemiology and Vaccinal Prevention. 2020; 19(4): 20-29. (In Russ.). doi: 10.31631/2073-3046-2020-19-4-20-29

9. Shugaeva SN, Savilov ED. Criteria for the integration of epidemic processes of HIV infection and tuberculosis. Tuberculosis and Lung Diseases. 2019; 97(5): 43-49. (In Russ.). doi: 10.21292/20751230-2019-97-5-43-48

10. Filinyuk OV, Alliluev AS, Аmichba DE, Golubchikov PN, Popelo YuS, Dobkina MN. HIV infection and multiple drug resistant tuberculosis: The frequency of co-infection and treatment efficacy. Tuberculosis and Lung Diseases. 2021; 99(2): 45-51. (In Russ.). doi: 10.21292/2075-1230-2021-99-2-45-51

11. The main indicators of anti-tuberculosis activity in the Siberian and Far Eastern federal districts (statistical materials). Novosibirsk; 2022. (In Russ.). URL: http://nsk-niit.ru/ftpgetfile.php?id=351 [date of access: 16.10.2022].

12. On the improvement of anti-tuberculosis measures in the Russian Federation: Order of the Ministry of Health of the Russian Federation N 109 d.d. 21.03.2003. URL: http://www.consultant.ru/document/cons_doc_LAW_100829/ [date of access: 18.10.2022]. (In Russ.).

13. Suppli CH, Norman A, Folkvardsen DB, Gissel TN, Weinreich UM, Koch A, et al. First outbreak of multidrug-resistant tuberculosis (MDR-TB) in Denmark involving six Danish-born cases. Int J Infect Dis. 2022; 117: 258-263. doi: 10.1016/j.ijid.2022.02.017

14. Bykov I, Dyachenko O, Ratmanov P, Liu H, Liang L, Wu Q. Factors contributing to the high prevalence of multidrug-resistance/Rifampicin-resistance in patients with tuberculosis: An epidemiological cross sectional and qualitative study from Khabarovsk krai region of Russia. BMC Infect Dis. 2022; 22(1): 612. doi: 10.1186/s12879-022-07598-7

15. Mozhokina GN, Samoylov AG, Vasilyeva IА. Prospects for expanding drug therapy for multiple drug resistant and extensively drug resistant tuberculosis. Tuberculosis and Lung Diseases. 2022; 100(3): 53-60. (In Russ.). doi: 10.21292/2075-1230-2022100-3-53-60

16. Nazarova OI (ed.). Epidemiological manifestations of HIV infection in the Omsk region for 2021: information bulletin. Omsk; 2022. (In Russ.).

17. Vasilyeva IA, Testov VV, Sterlikov SA. Tuberculosis situation in the years of the COVID-19 pandemic – 2020-2021. Tuberculosis and Lung Diseases. 2022; 100(3): 6-12. (In Russ.). doi: 10.21292/20751230-2022-100-3-6-12